Episode Details
Back to Episodes
GoodRx's Pharma Direct Surges, Beats Revenue Estimates
Description
GoodRxs Q1 earnings show a positive trend, with Pharma Direct segment growing by 82% YoY and steady engagement in subscription services. The company beat revenue estimates at $194M and raised full-year guidance. Despite a slight dip in operating margin, the overall picture is optimistic, driven by Pharma Direct growth. GoodRx attributes their success to brand recognition, doctor connections, and a wide pharmacy network. They plan to maintain Pharma Direct momentum, expand condition-specific subscriptions, and stabilize their core prescription business.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/3e9b8844419ff5b8